AmyPEarlyMDFACP

PubMed

• 2 citations
  Lack of racial differences in clinical outcomes of breast cancer patients receiving neoadjuvant chemotherapy: a single academic center study.
  Maithreyi Sarma, Stuthi Perimbeti, Samar Nasir, Kristopher Attwood, Ankita Kapoor, Tracey O'Connor, Amy Early, Ellis G Levine, Kazuaki Takabe, Pawel Kalinski, Christin...> ;Breast Cancer Research and Treatment. 2022 Apr 1
• 1 citations
  Survival outcomes of alternate dosing schedule of pemetrexed as maintenance therapy in NSCLC: Single institution experience.
  Mark G Faber, Chong Wang, Sruthi Kommi Reddy, Alison Meagher, Amy Early, Hongbin Chen, Grace K Dy> ;Lung Cancer. 2022 Mar 1
• 4 citations
  Real world outcomes with alpelisib in metastatic hormone receptor-positive breast cancer patients: A single institution experience.
  Sabah Alaklabi, Arya Mariam Roy, Kristopher Attwood, Anthony George, Tracey O'Connor, Amy Early, Ellis G Levine, Shipra Gandhi> ;Frontiers in Oncology. 2022 Jan 1
• 9 citations
  CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin.
  Jennifer K Lang, Badri Karthikeyan, Adolfo Quiñones-Lombraña, Rachael Hageman Blair, Amy P. Early, Ellis G. Levine, Javier G. Blanco, Tracey O'Connor> ;Cardio-Oncology. 2021 May 11
• 4 citations
  Breast Cancer and Secondary Cancer Recurrences After Autologous Tissue Reconstruction
  Amy P. Early, Wong Moon> ;Clinical Breast Cancer. 2021 Feb 1
• 22 citations
  Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib.
  Ajay Dhakal, Roby Antony Thomas, Ellis G. Levine, Adam Brufsky, Kazuaki Takabe, Matthew G. Hanna, Kristopher Attwood, Austin Miller, Thaer Khoury, Amy P. Early, Saif S...> ;Breast Cancer. 2020 Jul 23
• 13 citations
  Oncologist uptake of comprehensive genomic profile guided targeted therapy.
  , , , , , , , , , , , , , , , , , , , , > ;Oncotarget. 2019 Jul 23
• 59 citations
  Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Journal for Immunotherapy of Cancer. 2019 Feb 1
• 11 citations
  Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing
  Grace K. Dy, Mary Nesline, Antonios Papanicolau-Sengos, Paul DePietro, Charles LeVea, Amy P. Early, Hongbin Chen, Anne Grand'Maison, Patrick McKay Boland, Marc S. Erns...> ;BMC Medical Informatics and Decision Making. 2019 Jan 18
• 18 citations
  Efficacy of Palbociclib Combinations in Hormone Receptor–Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment
  Ajay Dhakal, Christina Matthews, Ellis G. Levine, Kilian E. Salerno, Fan Zhang, Kazuaki Takabe, Amy P. Early, Stephen B. Edge, Tracy O'Connor, Thaer Khoury, Jessica Yo...> ;Clinical Breast Cancer. 2018 Apr 28
• Neuroendocrine Carcinoma of the Breast With Endobronchial Metastases and Syndrome of Inappropriate Antidiuretic Hormone Secretion.
  Anaum Maqsood, Thaer Khoury, Prasanna Kumar, Amy P. Early> ;Clinical Breast Cancer. 2017 Mar 21
• 1 citations
  In Regard to Moran et al
  Amy P. Early> ;International Journal of Radiation Oncology, Biology, Physics. 2014 Aug 1
• 37 citations
  Current overview of the management of urogenital atrophy in women with breast cancer.
  Sandhya Pruthi, James A. Simon, Amy P. Early> ;The Breast Journal. 2011 Jul 1
• 73 citations
  Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia.
  Harvey D. Preisler, Azra Raza, Amy P. Early, Jeffrey Kirshner, M. Brecher, Arnold I. Freeman, Youcef M. Rustum, N. Azarnia, Roger L. Priore, A Sandberg> ;Journal of Clinical Oncology. 1987 May 1
• 5 citations
  Acute nonlymphocytic leukemia in a glue sniffer
  Michael A. Caligiuri, Amy P. Early, M. J. Marinello, Harvey D. Preisler> ;American Journal of Hematology. 1985 Sep 1
• 52 citations
  Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia.
  Harvey D. Preisler, Teresa Gessner, N. Azarnia, Wanda E. Bolanowska, Joshua Epstein, Amy P. Early, P. D'Arrigo, Ralph Vogler, Lee Winton, Paul Chervenik, Robert A. Joy...> ;Cancer Chemotherapy and Pharmacology. 1984 Jan 1
• 116 citations
  Therapy of secondary acute nonlymphocytic leukemia with cytarabine.
  Harvey D. Preisler, Amy P. Early, Azra Raza, George Vlahides, Michelle J. Marinello, Alfred M. Stein, George P. Browman> ;The New England Journal of Medicine. 1983 Jan 6
• 2 citations
  An Improved Method for T-Cell Depletion of Allogeneic Histoincompatible Donor Bone Marrow
  Howard Ozer, Tin Han, Amy P. Early, M. O'leary, D. Thompson, B. Dadey, N. Cohen, Donald J. Higby> ;Cancer Drug Delivery. 1983 Jan 1
• 47 citations
  The treatment of acute myelocytic leukemia in patients 30 years of age and younger
  Harvey D. Preisler, M. Brecher, George P. Browman, Amy P. Early, Irwin Walker, Azra Raza, Arnold I. Freeman> ;American Journal of Hematology. 1982 Nov 1
• 179 citations
  A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
  Amy P. Early, Harvey D. Preisler, Harry K. Slocum, Yosef M. Rustum> ;Cancer Research. 1982 Apr 1
• 25 citations
  High-dose cytosine arabinoside: Clinical response to therapy in acute leukemia
  Amy P. Early, Harvey D. Preisler, Donald J. Higby, Martin L. Brecher, George P. Browman, J.A. McBride> ;Medical and Pediatric Oncology. 1982 Jan 1
• 20 citations
  Relationship between plasma Ara-C and intracellular Ara-CTP pools under conditions of continuous infusion and high-dose Ara-C treatment.
  Youcef M. Rustum, H. K. Slocum, G. Wang, D. Bakshi, E. Kelly, D. Buscaglia, C. Wrzosek, Amy P. Early, H. Preisler> ;Medical and Pediatric Oncology. 1982 Jan 1
• 8 citations
  Treatment of refractory adult acute lymphocytic leukaemia and acute undifferentiated leukaemia with an anthracycline antibiotic and cytosine arabinoside.
  Amy P. Early, Harvey D. Preisler, Arlin J. Gottlieb, Neil A. Lanchant> ;British Journal of Haematology. 1981 Jul 1
• 8 citations
  Prevention of infection and bleeding in leukemic patients receiving intensive remission maintenance therapy.
  Harvey D. Preisler, Amy P. Early, W. Hryniuk> ;Medical and Pediatric Oncology. 1981 Jan 1
• Are K cells low-affinity E-rosetting cells?
  Amy P. Early, Howard Ozer> ;Lancet. 1979 Oct 6
• Join now to see all

Abstracts/Posters

• Immune Subsets by GI Tumor Type
  Early A, Pabla S, Conroy JM, Nesline MK, Glenn S, Papanicolau-Sengos A, Burgher B, Giamo V, Andreas J, DePietro P, Lenzo F,Wang Y, Morrison C, Society for Immunotherapy of Cancer 33rd Annual Meeting, Washington, DC, 11/9/2018

Lectures

• Immunotherapy and Targeted Therapy for Cancer of the Lung. City-Wide Grand Rounds 
  Jacobs Schoold of Medicine & Biomedical Sciences - 9/14/2017
• : Clinical Impact of Genomic Sequencing in Cancer of the Lung 
  Louisianna State University School of Medicine - 11/18/2016
• Early AP: Plenary Session. The Obesity Epidemic: Impact on Breast Cancer and Survivorship. National Consortium of Breast Centers Annual Interdisciplinary Breast Ce... 
• Early AP: Management of the Axilla while Minimizing Morbidity-The Roles of Surgery, Radiation, Systemic Therapy & Observation. National Consortium of Breast Cancers ... 
  3/14/2015
• Update on HER2+ Breast Cancer (Early & Advanced Stage) in 2015. Annual Interdisciplinary Breast Center Conference 
  Las Vegas, NV - 2/15/2015
• Join now to see all